Statins perhaps help to prevent HCC by suppressing oncogenic pathways including Rho-dependent kinase [19], tumor necrosis factor (TNF)-mediated interleukin (IL6) production [20], Akt [21], Myc-medicated cell proliferation, and so on [22] (Figure 1). Here, TNF is linked to hepatocellular carcinoma.